Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,290,627)	$ (1,347,234)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	35,958	5,409
Inventories impairment reserve	14,507
Allowance for doubtful accounts	(43,799)	(7,854)
Stock compensation	585,000
Lease expense	20,719
Amortization of discount of convertible promissory notes	1,607,105	294,958
Change in derivative liabilities		399,022
Change in operating assets and liabilities
Accounts receivable	(334,056)	(127,747)
Advances to suppliers	(387,940)	196,821
Prepayments and other receivables	281,718	(1,870,209)
Inventories	(2,572,438)	(267,692)
Operating lease-right of use assets	64,231
Accounts payable, trade	2,803,460	1,956,384
Advances from customers	329,591	(240,114)
operating lease liabilities	(95,368)
Taxes payable	(701,687)	(51,117)
Other payables and accrued liabilities	(46,085)	189,621
Net cash used in operating activities from continuing operations	(1,729,711)	(869,752)
Net cash provided by operating activities from discontinued operations		70,973
Net cash used in operating activities	(1,729,711)	(798,779)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash received from acquisition of Guanzan Group		95,220
Cash received from acquisition of Guoyitang Hospital	28,457
Cash received from acquisition of Zhongshan Hospital	46,748
Purchase of property, plant, and equipment	(36,100)
Net cash provided by investing activities	39,105	95,220
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from short-term loan	462,773
Repayment of long-term loan	(295,404)
Net proceeds from issuance of convertible promissory notes	4,065,000	593,224
Repayment of short-term loans	(4,419)
Amount financed from (to) related parties	164,067	297,599
Net cash provided by financing activities from continuing operations	4,392,017	890,823
Net cash used in financing activities from discontinued operations		(47,487)
Net cash provided by financing activities	4,392,017	843,336
EFFECT OF EXCHANGE RATE ON CASH	(1,295)	(280)
INCREASE IN CASH	2,700,116	139,497
CASH AND CASH EQUIVALENTS, beginning of period	135,308	36,674
CASH AND CASH EQUIVALENTS, end of period	2,835,424	176,171
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income tax	86,153
Cash paid for interest expense, net of capitalized interest	47,696
NON-CASH TRANSACTIONS OF INVESTING AND FINANCING ACTIVITIES
Issuance of common share for equity acquisition of Guoyitang Hospital	2,000
Issuance of common share for equity acquisition of Zhongshan Hospital	2,000
Issuance of common share for equity acquisition of Guanzan Group		2,717,000
Goodwill recognized from equity acquisition of Guanzan Group		6,443,170
Goodwill recognized from equity acquisition of Zhongshan Hospital	10,433,494
Goodwill recognized from equity acquisition of Guoyitang Hospital	7,154,392
Outstanding payment for the equity acquisition of Boqi Zhengji Group		5,655,709
Outstanding payment for equity acquisition of Guanzan Group	3,065,181
Outstanding payment for equity acquisition of Guoyitang Hospital	6,100,723
Outstanding payment for equity acquisition of Zhongshan Hospital	$ 6,100,723